V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20138414 | 20087679 | 1.78 | 79.8 | Adjuvant (A) | 2017-08-26 | 2017-08-28 | Pemetrexed | N | N | PRIMUS 002 TRIAL | 101577629 |
| 20138608 | 20087680 | 1.54 | 89.3 | 03 | 2017-06-30 | 2017-07-06 | CAP + RT | 01 | N | HYDROXYCARBAMIDE | 100027479 |
| 20138961 | 20087681 | 1.78 | 47.2 | Adjuvant (A) | 2016-07-16 | 2016-07-23 | GemCarbo Days 1+8 | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100308458 |
| 20139013 | 20087682 | 1.73 | 95 | Palliative (P) | 2018-11-02 | 2018-11-04 | Hydroxycarbamide | 02 | N | DOCETAXEL | 100499101 |
| 20139090 | 20087683 | 1.54 | 60 | Palliative (P) | 2018-10-17 | 2018-10-18 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 101257179 |
| 20139225 | 20087684 | 1.6 | 50 | Palliative (P) | 2018-02-19 | 2018-02-19 | ECarboX | N | N | FOXTROT TRIAL | 101131030 |
| 20139590 | 20087685 | 1.71 | 82.1 | Palliative (P) | null | 2019-11-16 | FCR Oral - Cycle 2 onwards | 01 | N | YTTRIUM-90 | 100410305 |
| 20139601 | 20087686 | null | 70.8 | 03 | 2017-09-23 | 2017-09-25 | ESPAC-4 TRIAL | 02 | N | ABIRATERONE | 101364005 |
| 20139650 | 20087687 | 1.57 | 84 | 03 | 2019-03-04 | 2019-03-16 | CAPECITABINE + OXALIPLATIN + RT | 01 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101453516 |
| 20139686 | 20087689 | 1.79 | 57.8 | Palliative (P) | 2016-07-25 | 2016-08-11 | Rituximab (INTRAVENOUS Maintenance) | 02 | N | GEMCITABINE + PACLITAXEL | 100253851 |
| 20139687 | 20087690 | 1.63 | 78 | 03 | 2017-12-31 | 2017-12-31 | FCarboSt | 02 | N | TEMOZOLOMIDE | 100870804 |
| 20139700 | 20087691 | 0 | 0 | 03 | 2019-10-20 | 2019-10-20 | Irinotecan 14day | 02 | N | ESPAC TRIAL | 100217476 |
| 20139972 | 20087692 | null | 63.4 | Palliative (P) | 2018-03-19 | 2018-03-29 | GemCarbo Days 1+8 | 02 | N | FLUOROURACIL + RT | 101249641 |
| 20140138 | 20087693 | null | null | Palliative (P) | 2019-07-25 | 2019-08-22 | PHITT C Carboplatin/Doxorubicin | 01 | N | SCOPE2 TRIAL | 100076313 |
| 20140316 | 20087694 | 1.71 | 70.2 | Palliative (P) | 2017-05-10 | 2017-05-25 | null | 02 | N | EVEROLIMUS | 100463450 |
| 20140413 | 20087695 | 1.58 | 70 | Palliative (P) | 2016-11-28 | 2016-12-10 | Cisplatin + Fluorouracil + RT 5day | 01 | N | CAPITAL TRIAL | 100691555 |
| 20140580 | 20087696 | 1.59 | null | null | 2019-01-12 | 2019-01-12 | OXALIPLATIN | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100031062 |
| 20140947 | 20087697 | 1.8 | 52.55 | Palliative (P) | null | 2021-12-30 | ARISTOTLE TRIAL | 01 | N | CISPLATIN + FLUOROURACIL + RT | 101144567 |
| 20140977 | 20087698 | 1.78 | 109 | Palliative (P) | null | 2017-01-15 | Gemcitabine + Paclitaxel | 2 | null | CYCLOPHOSPHAMIDE | 101042077 |
| 20141383 | 20087699 | 1.88 | 50.9 | 03 | 2020-03-11 | 2020-04-04 | Bortezomib (weekly) | 02 | Y | CAPITAL TRIAL | 100350891 |
| 20141452 | 20087700 | null | null | null | null | 2017-07-22 | Docetaxel 75mg/m2 (21 day) | N | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100507400 |
| 20141462 | 20087701 | 1.64 | 71.1 | Palliative (P) | 2018-12-27 | 2018-12-28 | Sunitinib | 02 | N | EOF | 101407468 |
| 20141589 | 20087702 | 1.49 | 90 | Adjuvant (A) | 2018-09-07 | 2018-09-29 | OXALIPLATIN | N | Y | PEMBROLIZUMAB | 101476490 |
| 20141745 | 20087705 | null | 40 | Palliative (P) | 2016-12-04 | 2016-12-21 | null | 02 | N | BUSULFAN | 101465889 |
| 20141778 | 20087706 | 1.77 | 86 | Palliative (P) | 2019-04-23 | 2019-04-28 | BUSULFAN | N | null | CISPLATIN + TEYSUNO | 100489781 |
| 20141836 | 20087707 | 1.68 | 86.6 | 03 | 2019-04-29 | 2019-05-11 | COSMIC TRIAL | 02 | N | CETUXIMAB + ENCORAFENIB | 101850898 |
| 20141937 | 20087708 | null | 72 | 03 | 2019-08-10 | 2019-08-19 | FOXTROT TRIAL | 02 | N | ACTICCA-1 TRIAL | 100679062 |
| 20141972 | 20087710 | 1.72 | 82.8 | 03 | 2019-11-09 | 2019-12-05 | ARISTOTLE TRIAL | 02 | Y | EOF | 100555691 |
| 20142155 | 20087711 | 1.66 | 76.5 | Palliative (P) | 2017-04-04 | 2017-04-05 | null | N | null | FCIST | 101201912 |
| 20142203 | 20087712 | 1.69 | 57 | Palliative (P) | 2017-03-10 | 2017-03-31 | CHOP R - 21 days | 02 | N | NOT MATCHED | 100254559 |
| 20142380 | 20087713 | 1.71 | 79.05 | 03 | null | 2019-01-03 | CVP R | null | N | NAB-PACLITAXEL | 101502304 |
| 20142414 | 20087714 | 1.6 | 68 | Palliative (P) | 2018-06-26 | 2018-07-08 | Irinotecan 14day | Y | N | CAP + RT | 100521092 |
| 20142471 | 20087715 | 1.82 | 82.5 | null | 2016-05-30 | 2016-06-06 | SCOPE 2 TRIAL | 02 | N | CAPECITABINE + CETUXIMAB + OXALIPATIN | 100134933 |
| 20142578 | 20087716 | 1.85 | 70.3 | Palliative (P) | 2017-05-10 | 2017-05-10 | Docetaxel 75mg/m2 (21 day) | N | N | CISPLATIN + FLUOROURACIL + RT | 100943522 |
| 20142601 | 20087717 | 1.54 | 72.4 | null | 2018-02-28 | 2018-03-04 | PHITT C SIOPEL-3HR | 02 | N | CAPECITABINE + STREPTOZOCIN | 100363501 |
| 20142633 | 20087718 | 1.64 | 60 | Palliative (P) | 2018-11-27 | 2019-11-08 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | NAB-PACLITAXEL | 100107551 |
| 20142845 | 20087719 | 1.85 | 89.9 | Palliative (P) | 2018-11-22 | 2018-12-19 | ESPAC-4 TRIAL | 1 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100183168 |
| 20142852 | 20087720 | 1.6 | 56.65 | Palliative (P) | 2019-03-09 | 2019-03-23 | CISPLATIN + FLUOROURACIL + RT | N | N | CTD | 101354838 |
| 20142915 | 20087721 | 1.75 | 83 | 03 | 2016-05-31 | 2016-05-31 | SCOPE 1 TRIAL | 02 | N | ABIRATERONE | 100097838 |
| 20143170 | 20087722 | 1.76 | 80.3 | 03 | 2018-03-28 | 2018-03-29 | BENDAMUSTINE + RITUXIMAB | 02 | N | CAP + RT | 101220913 |
| 20143228 | 20087723 | 1.5 | 85 | null | 2016-07-09 | 2016-07-11 | CISPLATIN + FLUOROURACIL + RT | N | null | MITOMYCIN | 101470244 |
| 20143244 | 20087724 | 1.85 | 88 | Adjuvant (A) | 2016-03-03 | 2016-03-03 | MELPHALAN + THALIDOMIDE | 01 | N | LENALIDOMIDE | 100190619 |
| 20143297 | 20087725 | 1.67 | 62 | 03 | 2018-09-09 | 2018-09-20 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100058319 |
| 20143370 | 20087726 | 1.68 | 47.8 | Palliative (P) | 2016-09-18 | 2016-10-15 | GemCarbo Days 1+8 | 02 | N | CYTARABINE | 100028118 |
| 20143402 | 20087727 | 1.64 | 94.4 | 03 | 2019-12-23 | 2019-12-23 | LIPOSOMAL DAUNORUBICIN + CYTARABINE (Vyxeos) | 02 | null | ARISTOTLE TRIAL | 100553504 |
| 20143492 | 20087729 | 1.59 | 86.4 | Adjuvant (A) | 2020-02-04 | 2020-02-18 | Erlotinib | N | N | HYDROXYCARBAMIDE | 100834785 |
| 20143583 | 20087730 | 1.71 | 100.7 | null | 2019-02-10 | 2019-02-21 | CAPECITABINE + LOMUSTINE | 01 | N | CARBOPLATIN + VINORELBINE | 100397692 |
| 20143649 | 20087731 | 1.6 | null | 03 | 2016-03-26 | 2016-03-27 | MPT | 02 | N | EOF | 101614916 |
| 20143702 | 20087732 | 1.7 | 101 | Palliative (P) | 2017-05-30 | 2017-06-06 | ECarboX | 02 | N | IBRUTINIB | 100482860 |
| 20143773 | 20087733 | 1.68 | 94.7 | null | 2020-07-03 | 2020-07-03 | PLATO Trials | 02 | N | PLATO TRIAL | 100104565 |